Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre B) track

Cell and Gene Therapies: SanBio Company Limited

Mon, Nov 9, 2026 · 1:00–1:15 PM CET Koelnmesse

About this session

SanBio Co., Ltd. is a regenerative medicine company with roots in the United States and Japan, dedicated to addressing high unmet medical needs in neurological disorders. Founded on leading stem cell research and focused on restoring function lost to injury and disease, SanBio aims to become a global leader in regenerative medicine through scientific innovation, clinical development, and commercialization.

Speaker

  • Keita Mori

    President · SanBio Company Limited

    Speaker